Toggle light / dark theme

Precision RNA therapy offers hope for brain receptor disorders

Scientists at Johns Hopkins University School of Medicine and Academia Sinica in Taiwan have developed an experimental RNA-based treatment that prevents brain damage and improves learning, memory and social behavior in mice carrying a rare genetic mutation associated with autism spectrum disorder and intellectual disability.

The research is published in the journal Neuron.

Through this research, the investigators showed how a mutation in GRIA1, a gene encoding a key component of AMPA receptors, disrupts brain development. These receptors control communication between neurons and are essential for learning and memory.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.